Argus Research has increased its price target for HCA Healthcare to $560 from $530, while reaffirming a Buy rating on the stock. This adjustment comes amidst other analyst revisions for HCA Healthcare, with some raising and others maintaining their ratings and price targets. The company operates 190 hospitals and numerous surgery and endoscopy centers primarily in the United States.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Argus Research Adjusts HCA Healthcare Price Target to $560 From $530, Maintains Buy Rating
Argus Research has increased its price target for HCA Healthcare to $560 from $530, while reaffirming a Buy rating on the stock. This adjustment comes amidst other analyst revisions for HCA Healthcare, with some raising and others maintaining their ratings and price targets. The company operates 190 hospitals and numerous surgery and endoscopy centers primarily in the United States.